Baron Opportunity Fund Inst Shs
Limited financial coverage for BIOIX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
This investment vehicle primarily commits capital to common equities issued by fast-growing American companies, irrespective of their market valuation, identified for their robust potential for value growth. The portfolio manager holds the prerogative to back enterprises across diverse economic sectors and industries, particularly those perceived to gain considerably from pioneering technological developments and innovation.
- IPO
- 2009
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on BIOIX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.42B
- Div Yield
- 3.30%
- 52W High
- $71.51
- 52W Low
- $51.14
- 50D MA
- $66.77
- 200D MA
- $61.03
- Beta
- 1.27
- RSI (14)
- 57
- Avg Volume
- 0
No earnings-call transcripts are available for BIOIX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 34.80M
- Float Shares
- 0
Our BIOIX coverage
Recent articles, reports, and earnings notes.
No research on BIOIX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIOIX report →